These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30958388)

  • 1. Brief Report: Hazardous Cannabis Use and Monocyte Activation Among Methamphetamine Users With Treated HIV Infection.
    Vidot DC; Manuzak JA; Klatt NR; Pallikkuth S; Roach M; Dilworth SE; Pahwa S; Carrico AW
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):361-364. PubMed ID: 30958388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection.
    Carrico AW; Cherenack EM; Roach ME; Riley ED; Oni O; Dilworth SE; Shoptaw S; Hunt P; Roy S; Pallikkuth S; Pahwa S
    AIDS; 2018 Mar; 32(6):767-771. PubMed ID: 29369159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial Correlates of Monocyte Activation and HIV Persistence in Methamphetamine Users.
    Grosgebauer K; Salinas J; Sharkey M; Roach M; Pallikkuth S; Dilworth SE; Pahwa S; Koru-Sengul T; Stevenson M; Carrico AW
    J Neuroimmune Pharmacol; 2019 Mar; 14(1):16-22. PubMed ID: 30046962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy.
    Carrico AW; Hunt PW; Neilands TB; Dilworth SE; Martin JN; Deeks SG; Riley ED
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):89-93. PubMed ID: 30272634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine.
    Carrico AW; Neilands TB; Dilworth SE; Evans JL; Gόmez W; Jain JP; Gandhi M; Shoptaw S; Horvath KJ; Coffin L; Discepola MV; Andrews R; Woods WJ; Feaster DJ; Moskowitz JT
    J Int AIDS Soc; 2019 Dec; 22(12):e25436. PubMed ID: 31860172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.
    Manuzak JA; Gott TM; Kirkwood JS; Coronado E; Hensley-McBain T; Miller C; Cheu RK; Collier AC; Funderburg NT; Martin JN; Wu MC; Isoherranen N; Hunt PW; Klatt NR
    Clin Infect Dis; 2018 Jun; 66(12):1872-1882. PubMed ID: 29471387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over the influence: The HIV care continuum among methamphetamine-using men who have sex with men.
    Jin H; Ogunbajo A; Mimiaga MJ; Duncan DT; Boyer E; Chai P; Dilworth SE; Carrico AW
    Drug Alcohol Depend; 2018 Nov; 192():125-128. PubMed ID: 30248558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct inflammatory profiles in HIV-infected individuals under antiretroviral therapy using cannabis, cocaine or cannabis plus cocaine.
    Castro FOF; Silva JM; Dorneles GP; Barros JBS; Ribeiro CB; Noronha I; Barbosa GR; Souza LCS; Guilarde AO; Pereira AJCS; Guimarães RF; Oliveira TF; Oliveira SEF; Peres A; Romão PRT; Pfrimer IAH; Fonseca SGD
    AIDS; 2019 Oct; 33(12):1831-1842. PubMed ID: 31490211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users.
    Scott LA; Roxburgh A; Bruno R; Matthews A; Burns L
    Addict Behav; 2012 Sep; 37(9):1058-62. PubMed ID: 22607716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment.
    Fuster D; García-Calvo X; Bolao F; Zuluaga P; Rocamora G; Hernández-Rubio A; Sanvisens A; Tor J; Muga R
    Drug Alcohol Depend; 2020 Nov; 216():108231. PubMed ID: 32818911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco, alcohol, cannabis, and illicit drug use and their association with CD4/CD8 cell count ratio in people with controlled HIV: a cross-sectional study (ANRS CO3 AQUIVIH-NA-QuAliV).
    Devos S; Bonnet F; Hessamfar M; Neau D; Vareil MO; Leleux O; Cazanave C; Rouanes N; Duffau P; Lazaro E; Dabis F; Wittkop L; Barger D;
    BMC Infect Dis; 2023 Jan; 23(1):16. PubMed ID: 36624391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blue Monday: Co-occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis.
    Chahine A; Koru-Sengul T; Feaster DJ; Dilworth SE; Antoni MH; Klatt N; Roach ME; Pallikkuth S; Sharkey M; Salinas J; Stevenson M; Pahwa S; Fuchs D; Carrico AW
    J Acquir Immune Defic Syndr; 2021 Mar; 86(3):353-360. PubMed ID: 33165125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Getting to the point: Methamphetamine injection is associated with biomarkers relevant to HIV pathogenesis.
    Miller M; Lee JY; Fulcher JA; Roach ME; Dilworth SE; Chahine A; Pallikkuth S; Fuchs D; Pahwa S; Carrico AW
    Drug Alcohol Depend; 2020 Aug; 213():108133. PubMed ID: 32580112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men.
    Parsons JT; Kowalczyk WJ; Botsko M; Tomassilli J; Golub SA
    AIDS Behav; 2013 May; 17(4):1478-87. PubMed ID: 23553345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine use and its associations with antiretroviral adherence and viral load among sexual minority men and transgender women living with HIV.
    Brousseau NM; Kalichman SC; Watson RJ; Eaton LA
    AIDS Care; 2023 Oct; 35(10):1472-1479. PubMed ID: 37139536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual Minority Stress and Cellular Aging in Methamphetamine-Using Sexual Minority Men With Treated HIV.
    Ghanooni D; Carrico AW; Williams R; Glynn TR; Moskowitz JT; Pahwa S; Pallikkuth S; Roach ME; Dilworth S; Aouizerat BE; Flentje A
    Psychosom Med; 2022 Oct; 84(8):949-956. PubMed ID: 35980781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine Use Associated with Non-adherence to Antiretroviral Treatment in Men Who Have Sex with Men.
    Lai HH; Kuo YC; Kuo CJ; Lai YJ; Chen M; Chen YT; Chen CC; Yen MY; Hu BS; Wang TH; Wang CC; Kuo LL; Yen TF; Chuang PH; Yen YF
    Sci Rep; 2020 Apr; 10(1):7131. PubMed ID: 32346081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative impact of methamphetamine and other drug use on viral suppression among sexual minority men on antiretroviral therapy.
    Fulcher JA; Javanbakht M; Shover CL; Ragsdale A; Brookmeyer R; Shoptaw S; Gorbach PM
    Drug Alcohol Depend; 2021 Apr; 221():108622. PubMed ID: 33631545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection.
    Carrico AW; Flentje A; Kober K; Lee S; Hunt P; Riley ED; Shoptaw S; Flowers E; Dilworth SE; Pahwa S; Aouizerat BE
    Brain Behav Immun; 2018 Jul; 71():108-115. PubMed ID: 29679637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection.
    Lee J; Lee JY; Meade CS; Cohn M; Chahine A; Dilworth SE; Magidson JF; Gouse H; Fuchs D; Carrico AW
    J Neurovirol; 2020 Oct; 26(5):779-784. PubMed ID: 32728896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.